STOCK TITAN

Alcon Inc SEC Filings

ALC NYSE

Welcome to our dedicated page for Alcon SEC filings (Ticker: ALC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Alcon Inc. (ALC) SEC filings page provides access to the company’s U.S. regulatory disclosures as a foreign private issuer. Alcon files annual reports on Form 20-F and current reports on Form 6-K under the Securities Exchange Act of 1934. These filings include press releases, interim financial reports and other information that help investors understand the company’s operations in eye care and ophthalmic goods manufacturing.

Form 6-K submissions are a key source of timely information. Recent 6-Ks have furnished press releases about corporate actions and financial reporting, such as the November 12, 2025 filing that included a press release and an interim financial report, and the January 6, 2026 filing that attached a press release regarding the termination of Alcon’s merger agreement with STAAR Surgical Company. Another 6-K dated August 5, 2025 furnished a press release related to company developments.

Alcon’s filings also provide structured data on its business segments and financing. Segment disclosures in its interim financial reporting distinguish between the Surgical and Vision Care segments and further categorize areas such as implantables, consumables, equipment, contact lenses and ocular health. Other filing content details geographic reporting areas, debt instruments, and fair value measurements for financial assets and derivatives.

On this page, AI-powered tools can summarize lengthy Alcon filings, highlight key points from annual reports on Form 20-F and interim information furnished on Form 6-K, and help explain segment data and transaction disclosures. Users can review historical filings to track how Alcon reports on its Surgical and Vision Care businesses, capital structure and significant corporate events, including agreements and terminations related to mergers.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Alcon (ALC)?

The current stock price of Alcon (ALC) is $84.21 as of March 4, 2026.

What is the market cap of Alcon (ALC)?

The market cap of Alcon (ALC) is approximately 40.5B.

ALC Rankings

ALC Stock Data

40.50B
490.51M
Medical Instruments & Supplies
Healthcare
Link
Switzerland
Geneva

ALC RSS Feed